Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
about
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2HIV enters cells via endocytosis and dynamin-dependent fusion with endosomesSERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by NefHIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationIdentification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus researchRemodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and PersistenceImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoAssembly of the murine leukemia virus is directed towards sites of cell-cell contactThe identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancementHIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particlesIn vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix.HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity.Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef proteinThe functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coliTetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.The role of dynamin in HIV type 1 Env-mediated cell-cell fusion.How HIV-1 takes advantage of the cytoskeleton during replication and cell-to-cell transmissionThe ∼ 16 kDa C-terminal sequence of clathrin assembly protein AP180 is essential for efficient clathrin binding.Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogensNef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.Association with PAK2 Enables Functional Interactions of Lentiviral Nef Proteins with the Exocyst Complex.Correction of a carboxyl terminal simian immunodeficiency virus Nef frameshift mutation restores virus replication in macaques.Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.Dynamin, a membrane-remodelling GTPase.Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.Down-modulation of primate lentiviral receptors by Nef proteins of simian immunodeficiency virus (SIV) of chimpanzees (SIVcpz) and related SIVs: implication for the evolutionary event at the emergence of SIVcpz.HIV-1 Nef: at the crossroadsNef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.UPF1 is crucial for the infectivity of human immunodeficiency virus type 1 progeny virions.Mechanisms of HIV-1 Nef function and intracellular signaling.Dynamin 2 is essential for mammalian spermatogenesis.HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivityThe Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
P2860
Q21559418-392E90DA-439B-4166-B802-79D9874B58E4Q22252313-D9A8DEA5-8019-4CE8-9FDF-DC24FBE2E15FQ24338889-C312A725-D344-4ED5-B15F-E90CEF5D8257Q24338895-F65DA535-D339-4FA6-9884-1CAF9A223642Q24651042-8EAAFE1F-A354-422B-8C84-471C062C3945Q26767362-373A3A72-6CAC-478E-BEBF-6D060AF76D4AQ26851152-04857AFE-97FE-4B88-BCBB-29D08F76E76BQ27329731-09B3E54E-2289-411D-840E-CDDB27D13830Q28477983-3B65579F-7B1B-4603-BC0C-BB4710DAF8A2Q28538038-A4F92E93-CBF7-4621-A00F-DD85F501B265Q30009533-CE91DA31-B3C4-4373-9EE2-C185E0C2BBF0Q30010085-2E12C096-D3AD-42B1-A5D0-9954DD4389EEQ30833678-B070BD23-D7DB-4D72-BFBE-64A17A49B572Q33307477-80A12006-D9F1-4F94-B593-427856B5D5FBQ33891972-A76E5B07-3A3E-4F31-A45E-E007498593ACQ33927183-C94780CB-3DA9-49F3-9AE1-59148AE86F82Q34109778-A7D6E90E-FF8C-4D73-9DA4-66521105C271Q34483109-18405A43-0027-4679-B074-4D2283601E42Q34819697-E3B199E1-F99C-448F-8E10-ADFB7C05C6C0Q35076592-6D4D40AE-CBCD-40B6-AE0B-696E84CAEB55Q35179370-788C5AD3-B907-4BE6-9E2C-8D35686CF03BQ35276711-93350DE7-21A4-449F-99A8-2CF4356F6384Q35348056-2F07DA15-B387-45A2-9047-885D97A219B3Q35383008-FDF94F6E-38F3-475F-B724-474F0A76CC2FQ36112824-FBA7610E-EA99-403A-9863-1421707CD8F9Q36143620-B2DAAB78-CBFF-4868-9CC1-21C07CDD11AFQ36161747-ABAABA01-FE2D-4D60-8A8A-A43EE7EE1A07Q36364322-3022CC53-1BD1-4D4C-9845-B5797657D270Q36460251-92A9F40D-0A05-4E66-9A12-20B61B8F9F5BQ36759728-925FCA85-11BE-456B-A115-91E76799FE10Q36871889-CA396CAB-195F-47D6-AD12-E6F1DC9CA388Q36926697-0C002EC1-4A62-4795-B3A5-15C86646E1B1Q36949578-A4C19745-1AC5-42BB-9023-7F7A4EA3591DQ37123249-AE8760F1-DF8F-4423-8266-3BB4104E2F7AQ37183848-BA8AB85F-3D07-4F0D-AEAD-253BCB6F0258Q37325397-61A09238-7C6D-4D95-A3BA-3577187AC4A3Q37396102-D97EAA72-A926-4428-A264-49527447A47DQ37415400-AB0CE03B-0E66-4B99-8EFF-82C70D2BEB44Q37469506-AF9ED1AA-E586-4679-A8E9-ED07B88165F1Q37643789-60C1588C-7B97-4576-9951-19B0FEE01D1F
P2860
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@ast
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@en
type
label
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@ast
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@en
prefLabel
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@ast
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@en
P2093
P2860
P356
P1476
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
@en
P2093
Anna Helander
Arianna Calistri
Elena Popova
Heinrich G Göttlinger
Massimo Pizzato
P2860
P304
P356
10.1073/PNAS.0607622104
P407
P577
2007-04-05T00:00:00Z